Compare IMA & NBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMA | NBRG |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 76.0M |
| IPO Year | 2021 | 2025 |
| Metric | IMA | NBRG |
|---|---|---|
| Price | $4.24 | $10.09 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 13.6K | ★ 21.3K |
| Earning Date | 11-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.90 | $9.59 |
| 52 Week High | $9.10 | $10.09 |
| Indicator | IMA | NBRG |
|---|---|---|
| Relative Strength Index (RSI) | 23.41 | 65.96 |
| Support Level | $3.94 | $9.96 |
| Resistance Level | $6.10 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 23.26 | 100.00 |
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Newbridge Acquisition Ltd is a blank check company.